Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
Thuy Vu(Lawrence Livermore National Laboratory), François X. Claret(The University of Texas MD Anderson Cancer Center)
Cited by 606
Related Papers
Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells
|Journal of Biological Chemistry|2003|384
Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
|PLoS ONE|2013|133
Achieving utility with family history
|American Journal of Preventive Medicine|2003|18